High IKZF1/3 protein expression is a favorable prognostic factor for survival of relapsed/refractory multiple myeloma patients treated with lenalidomide

The aim of this study is to assess nucleoprotein expression of IKZF1/3 in patients with relapsed/refractory multiple myeloma (MM) who received lenalidomide-based therapy and correlated them with their clinical outcomes. A total of 50 patients diagnosed with MM were entered in the study with the medi...

Descripción completa

Detalles Bibliográficos
Autores principales: Pourabdollah, Maryam, Bahmanyar, Mohammad, Atenafu, Eshetu G., Reece, Donna, Hou, Jian, Chang, Hong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5120536/
https://www.ncbi.nlm.nih.gov/pubmed/27881177
http://dx.doi.org/10.1186/s13045-016-0354-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5120536/
https://www.ncbi.nlm.nih.gov/pubmed/27881177
http://dx.doi.org/10.1186/s13045-016-0354-2

Ejemplares similares